These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1908891)

  • 1. Duration of etidronate effect demonstrated by serial bone scintigraphy.
    Sandler ED; Parisi MT; Hattner RS
    J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
    Hommeyer SH; Varney DM; Eary JF
    J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
    Murphy KJ; Line BR; Malfetano J
    Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etidronate sodium therapy--a cause of poor skeletal radiopharmaceutical uptake.
    DeMeo JH; Balseiro J; Cole TJ
    Semin Nucl Med; 1991 Oct; 21(4):332-4. PubMed ID: 1754895
    [No Abstract]   [Full Text] [Related]  

  • 5. False-negative bone imaging due to etidronate disodium therapy.
    Krasnow AZ; Collier BD; Isitman AT; Hellman RS; Ewey D
    Clin Nucl Med; 1988 Apr; 13(4):264-7. PubMed ID: 3131057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
    de La Rochefoucauld B; Basset JY; Rondier J; Cayla J; Ancri D
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):575-9. PubMed ID: 6241965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate for hypercalcemia of malignancy and osteoporosis.
    Horowitz E; Miller JL; Rose LI
    Am Fam Physician; 1991 Jun; 43(6):2155-9. PubMed ID: 1904188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: intravenous etidronate as a cause of poor uptake on bone scanning, with a review of the literature.
    Chong WK; Cunningham DA
    Clin Radiol; 1991 Oct; 44(4):268-70. PubMed ID: 1835685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
    Kawamura J; Tochigi H; Yanagawa M; Yoshida O; Hida S; Mori O; Suzuki N; Saito K; Komatsu Y; Hatayama T
    Hinyokika Kiyo; 1988 Mar; 34(3):528-37. PubMed ID: 3133934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
    Basoglu T; Canbaz F; Bernay I
    J Nucl Med; 1998 Dec; 39(12):2034, 5A. PubMed ID: 9867137
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
    Kanis JA; Urwin GH; Gray RE; Beneton MN; McCloskey EV; Hamdy NA; Murray SA
    Am J Med; 1987 Feb; 82(2A):55-70. PubMed ID: 3103437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical etidronate treatment of osteoporosis.
    N Engl J Med; 1990 Dec; 323(23):1633-5. PubMed ID: 2122254
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
    Lee JY
    Clin Nucl Med; 1981 Aug; 6(8):356-8. PubMed ID: 6455232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual scintigraphic findings in a case of treated monostotic Paget's disease.
    Ziewacz JT; Slavin JD; Spencer RP
    Clin Nucl Med; 1988 Feb; 13(2):93-5. PubMed ID: 3127101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.